2004
DOI: 10.1016/j.jpba.2004.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a liquid chromatographic method for determination of related-substances of mosapride citrate in bulk drugs and pharmaceuticals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 9 publications
1
2
0
Order By: Relevance
“…The mass transition m/z 422 → 198 for mosapride confirmed several previous reports [15,22,23]. The fragmentation pathways have been described previously in several papers [15,22,26].…”
Section: Methods Developmentsupporting
confidence: 88%
See 1 more Smart Citation
“…The mass transition m/z 422 → 198 for mosapride confirmed several previous reports [15,22,23]. The fragmentation pathways have been described previously in several papers [15,22,26].…”
Section: Methods Developmentsupporting
confidence: 88%
“…High-performance liquid chromatography (HPLC) with UV detection was used to determine mosapride in bulk drugs or pharmaceutical preparations [13][14][15]. The enantioseparation and enantioselective determination by HPLC with UV detection [16,17] or HPLC with fluorometric detection [18] were also reported.…”
Section: Introductionmentioning
confidence: 99%
“…The mobile phase was a solution of HPLC-grade methanol, water, glacial acetic acid and triethylamine at a ratio of 1600:400:05:1 (RAO et al, 2004) which was injected into the system at a flow rate of 0.8ml/min after being filtered through a 0.45mm membrane filter. The column temperature was kept at 30°C, and the spectrophotometer was set to a detection wavelength of 274nm.…”
Section: Evaluation Of Tabletsmentioning
confidence: 99%